Longeveron (LGVN) Capital Expenditures Growth (1y) (2021 - 2025)
Longeveron (LGVN) Capital Expenditures Growth (1y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Longeveron |
20.35 Bn |
20.33 Bn |
264,000.00 |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-86.74% |
| Jun 30, 2025 |
-17.86% |
| Mar 31, 2025 |
68.75% |
| Dec 31, 2024 |
-92.07% |
| Sep 30, 2024 |
14,233.33% |
| Jun 30, 2024 |
113.04% |
| Mar 31, 2024 |
-61.90% |
| Dec 31, 2023 |
148.48% |
| Sep 30, 2023 |
-99.21% |
| Jun 30, 2023 |
17.95% |
| Mar 31, 2023 |
-10.64% |
| Dec 31, 2022 |
-78.85% |
| Dec 31, 2021 |
2,500.00% |
